Reckitt Benckiser Group plc

Reckitt Benckiser Group plc

RBGPF
Reckitt Benckiser Group plcUS flagOther OTC
60.93
USD
+0.92
- -
38.81BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
13.44
12.77
12.96
14.02
16.98
18.59
18.88
20.5
19.31
21.05
21.23
21.07
21.78
13.61
Basic EPS, GAAP
2.52
4.66
2.55
2.71
9.15
3.19
-5.41
1.74
-0.05
3.39
2.39
2.12
4.88
2.5
Free Cash Flow per Basic Share
2.75
2.77
2.34
3.01
3.18
3.08
1.42
4.44
1.82
2.85
3.18
3.3
2.58
2.5
Dividend per Share
1.44
1.43
1.35
1.53
1.68
1.75
1.8
1.82
1.82
1.82
1.95
2.05
2.15
- -
Book Value per Share
30.16
31.27
31.9
32.37
40.19
41.72
34.43
34.39
32.93
34.53
34.13
32.82
35.98
28.33
Tangible Book Value per Share
-6.97
-6.38
-6.41
-7.44
-23.63
-22.88
-21.83
-20.25
-16.66
-15.61
-14.71
-16.13
-12.31
-6.42
Basic Weighted Avg Shares
690
692
685
676
674
678
680
682
685
687
688
672
652
697
Sales/Revenue/Turnover
9,266
8,836
8,874
9,480
11,449
12,597
12,846
13,993
13,234
14,453
14,607
14,169
14,205
9,485
Operating Margin (%)
23.13
24.73
26.75
27.81
26.89
26.13
24.61
22.48
20.51
23.54
22.91
24.27
24.12
26.17
Depreciation Expense
155
161
171
177
268
409
5,552
1,455
429
604
470
461
499
- -
Net Income, GAAP
1,739
3,223
1,743
1,832
6,172
2,159
-3,683
1,187
-32
2,330
1,643
1,426
3,182
1,745
Effective Tax Rate (%)
24.41
21.73
20.97
23.08
- -
19.71
- -
38.44
- -
23.18
31.36
31.94
16.55
26.18
Profit Margin (%)
18.77
36.48
19.64
19.32
53.91
17.14
-28.67
8.48
-0.24
16.12
11.25
10.06
22.4
18.4
Working Capital
-2,760
-2,129
-2,157
-1,951
-1,200
-2,717
-3,898
-1,624
-3,083
-3,056
-3,036
-3,345
-1,015
-2,762
LT Debt
598
636
671
804
11,797
9,950
8,545
9,794
7,078
7,163
6,858
7,235
7,620
3
Total Equity
6,336
6,834
6,906
8,426
13,557
14,771
9,407
9,159
7,453
9,483
8,469
6,720
7,781
5,781
Return on Invested Capital (%)
17.21
17.97
19.6
19.89
- -
9.82
- -
9.28
- -
14.31
12.4
13.82
17.32
21.87
Return on Capital (%)
7.53
13.64
7.33
7.7
- -
5.99
- -
3.85
- -
7.68
5.69
5.39
11.26
8.01
Return on Common Equity (%)
8.5
15.19
8.02
8.38
25.2
7.8
-14.25
5.06
-0.14
10.07
6.96
6.26
13.98
9.03

Capital Structure

FRC

in mil. unless spec.
Jun'11
Sep'11
Dec'11
ST Debt
2,849
- -
2,505
LT Borrowings
3
- -
3
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
699
699
699
Market Capitalization
16,447
15,342
14,957

Working Capital

FRC

in mil. unless spec.
Jun'11
Sep'11
Dec'11
Total Current Assets
2,981
- -
2,938
Cash, Cash Equivalents & STI
581
- -
650
Accounts Receivable, Net
1,450
- -
1,247
Inventories
742
- -
758
Total Current Liabilities
6,191
- -
5,700
Payables & Accruals
- -
- -
- -
ST Debt
2,849
- -
2,505
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.6%
-1.39%
15.79%
Free Cash Flow
17.6%
-2.6%
-24.13%
Net Income, GAAP
-762.93%
-1,480.7%
123.14%
Sales/Revenue/Turnover
5.06%
0.42%
0.25%
Total Cash Common Dividend
4.33%
2.52%
1.59%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
14,607
2024
- -
- -
- -
- -
14,169
2025
- -
- -
- -
- -
14,205

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.39
2024
- -
- -
- -
- -
2.12
2025
- -
- -
- -
- -
4.88

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.95
2024
- -
- -
- -
- -
2.05
2025
- -
- -
- -
- -
2.15

Company Description

APIChat
CEO
Kristoffer Loe Licht
Full Time Employees
37,900
Sector
Consumer Defensive
Industry
Household & Personal Products
Address
Turner House Slough United Kingdom SL1 3UH
IPO Date
Nov 7, 2007
Business
Reckitt Benckiser Group plc is a British multinational consumer goods company headquartered in Slough, United Kingdom, engaged in the manufacture and sale of health, hygiene, and nutrition products globally. Founded in 1999 through the merger of Reckitt & Colman plc and Benckiser NV, Reckitt organizes its business into three primary segments: Health, Hygiene, and Nutrition. Its Health segment includes over-the-counter (OTC) medicines, germ protection solutions, intimate wellness products, vitamins, minerals and supplements (VMS), and personal care items with flagship brands such as Mucinex, Strepsils, Gaviscon, Nurofen, and Biofreeze. The Hygiene segment covers surface and disinfection products, auto dishwash products, air care, fabric additives, lavatory care, and related categories with leading global brands including Lysol, Dettol, Harpic, Finish, and Vanish. The Nutrition segment offers infant and child nutrition products along with specialized nutritional solutions. Reckitt’s products are distributed across nearly 200 countries with a global network of distribution and embellishment centers. In major recent strategic developments, Reckitt has focused on sharpening its portfolio around high-growth and high-margin Powerbrands, divesting its Essential Home business, which includes home care brands like Cillit Bang and Calgon, to Advent International in 2025 while retaining a 30% equity stake, signaling a strategic shift toward a simpler, more focused consumer health and hygiene company. The company acquired the Biofreeze brand in 2021 to strengthen its presence in the pain relief category. Reckitt continues to drive innovation and market share growth in its core categories through product enhancements and sustained marketing investments, evidenced by strong growth in brands such as Lysol and Finish in 2024. These moves align with Reckitt’s strategy to focus on its top 19 most profitable brands, expected to generate 70% of net revenues, furthering its commitment to premium, high-growth segments with improved operational efficiency and shareholder value creation. Reckitt operates principally in the fast-moving consumer goods (FMCG) industry targeting retail consumers worldwide with a strong presence in the US, UK, China, and other key markets. The company employs over 35,000 people and maintains a robust global footprint with 131 distribution centers across 51 countries. Reckitt's strategic focus on health and hygiene, combined with its divestiture of non-core portfolios, positions the company to accelerate growth and margin expansion through leadership in consumer health, hygiene, and nutrition categories.

Company News

APIChat
  • Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth

  • Swiss bank sees upside for Reckitt Benckiser though the Dettol and Durex owner needs to "rebuild trust"

  • Reckitt stock dips on Q1 miss: what's really ailing the health giant?

  • Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance

  • Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript

  • Reckitt not yet rewarded for improved earnings model, says UBS after strong quarter

  • Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript

  • Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress

  • Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets

  • Reckitt Benckiser Group (OTCMKTS:RBGPF) Stock Price Down 0.3% – What’s Next?

  • Reckitt downgraded by RBC as Deutsche Bank strikes more bullish tone

  • Reckitt to pay £1.6bn special dividend after Essential Home sale

  • Avatars, influencers in China livestreams help drive Reckitt's emerging-market led growth

  • Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript

  • Reckitt steadies its course as bank lifts target

  • Reckitt Benckiser Logs Higher Sales as Consumers Spend on Self-Care

  • Reckitt Benckiser Group Plc. ADR (RBGLY) Q3 2025 Sales Call Transcript

  • Reckitt Benckiser sales swell faster than expected as Durex and Dettol outperform

  • Reckitt Benckiser's performance not to be sniffed at, says leading bank

  • RBGLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reckitt Benckiser Group PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit